Publications by authors named "Chris Hebert"

Claim this Profile
P
Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma.
Drew W Rasco, Theresa Medina, Pippa Corrie, Anna C Pavlick, Mark R Middleton, Chris Hebert

Cancer Chemother Pharmacol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory Mechanics in a Cohort of Critically Ill Subjects With COVID-19 Infection.
August Longino, Toni Riveros, Erik Risa, Chris Hebert, Joshua Krieger

Respir Care· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergency department characteristics and associations with intensive care admission among patients with coronavirus disease 2019.
Joshua Krieger, Flynn McGuire, Erik Risa, August Longino, Steven Coppess, Chris Hebert

J Am Coll Emerg Physicians Open· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical insights into the use of embolic protection devices during lower extremity peripheral vascular interventions.
David E Allie, Agostino Ingraldi, Raghotham R Patlola, Chris J Hebert, Craig M Walker

J Invasive Cardiol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
24-carat gold, 14-carat gold, or platinum standards in the treatment of critical limb ischemia: bypass surgery or endovascular intervention?
David E Allie, Chris J Hebert, Agostino Ingraldi, Raghotham R Patlola, Craig M Walker

J Endovasc Ther· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted renal therapy and contrast-induced nephropathy during endovascular abdominal aortic aneurysm repair: results of a feasibility pilot trial.
David E Allie, Mitchell D Lirtzman, Charles H Wyatt, V Antoine Keller, Elena V Mitran, Chris J Hebert

J Endovasc Ther· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of the early experience with Targeted Renal Therapy for renal function preservation during endovascular and surgical treatments for cardiovascular disease.
David E Allie, Chris J Hebert, Raghotham Patlola, Mitchell D Lirtzman, Charles H Wyatt

EuroIntervention· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifactorial acute renal failure treated with percutaneous targeted renal therapy (TRT): a case of "dialysis rescue".
David E Allie, Chris J Hebert, Craig M Walker

J Invasive Cardiol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A safety and feasibility report of combined direct thrombin and GP IIb/IIIa inhibition with bivalirudin and tirofiban in peripheral vascular disease intervention: treating critical limb ischemia like acute coronary syndrome.
David E Allie, Chris J Hebert, Mitchell D Lirtzman, Charles H Wyatt, V Antoine Keller

J Invasive Cardiol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical limb ischemia: a global epidemic.A critical analysis of current treatment unmasks the clinical and economic costs of CLI.
David E Allie, Chris J Hebert, Mitchell D Lirtzman, Charles H Wyatt, V Antoine Keller

EuroIntervention· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel simultaneous combination chemical thrombolysis/rheolytic thrombectomy therapy for acute critical limb ischemia: the power-pulse spray technique.
David E Allie, Chris J Hebert, Mitchell D Lirtzman, Charles H Wyatt, V Antoine Keller

Catheter Cardiovasc Interv· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel treatment strategy for leg and sternal wound complications after coronary artery bypass graft surgery: bioengineered Apligraf.
David E Allie, Chris J Hebert, Mitchell D Lirtzman, Charles H Wyatt, V Antoine Keller

Ann Thorac Surg· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous tenecteplase infusion combined with peri/postprocedural platelet glycoprotein IIb/IIIa inhibition in peripheral arterial thrombolysis: initial safety and feasibility experience.
David E Allie, Chris J Hebert, Mitchell D Lirtzman, Charles H Wyatt, V Antoine Keller

J Endovasc Ther· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraoperative innominate and common carotid intervention combined with carotid endarterectomy: a "true" endovascular surgical approach.
David E Allie, Chris J Hebert, Mitchell D Lirtzman, Charles H Wyatt, Mohamed H Khan

J Endovasc Ther· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bivalirudin as a foundation anticoagulant in peripheral vascular disease: a safe and feasible alternative for renal and iliac interventions.
David E Allie, Mitchell D Lirtzman, Charles H Wyatt, V Antoine Keller, Mohamed H Khan, Chris J Hebert

J Invasive Cardiol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis